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Abstract
DNA-protein crosslinks (DPCs) arise from a wide range of endogenous and exogenous chemicals, 
such as chemotherapeutic drugs and formaldehyde. Importantly, recent identification of aldehydes 
as endogenous genotoxins in Fanconi anemia has provided new insight into disease causation. Due 
to their bulky nature, DPCs pose severe threats to genome stability, but previous methods to 
measure formaldehyde-induced DPCs were incapable of discriminating between endogenous and 
exogenous sources of chemical. In this study, we developed methods that provide accurate and 
distinct measurements of both exogenous and endogenous DPCs in a structurally-specific manner. 
We exposed experimental animals to stable isotope-labeled formaldehyde ([13CD2]-formaldehyde) 
by inhalation and performed ultrasensitive mass spectrometry to measure endogenous (unlabeled) 
and exogenous (13CD2-labeled) DPCs. We found that exogenous DPCs readily accumulated in 
nasal respiratory tissues, but were absent in tissues distant to the site of contact. This observation 
together with the finding that endogenous formaldehyde-induced DPCs were present in all tissues 
examined suggests that endogenous DPCs may be responsible for increased risks of bone marrow 
toxicity and leukemia. Furthermore, the slow rate of DPC repair provided evidence for persistence 
of DPCs. In conclusion, our method for measuring endogenous and exogenous DPCs presents a 
new perspective for the potential health risks inflicted by endogenous formaldehyde, and may 
inform improved disease prevention and treatment strategies.
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Introduction
DNA damage is a major culprit in many diseases, including cancer and aging. Toxic 
chemicals originating from a wide range of endogenous and exogenous sources continuously 
damage DNA (1). It is well known that our DNA is not pristine and endogenous DNA 
damage occurs at a high frequency compared with exogenous damage, having more than 
40,000 lesions in every cell in our body (2). The “Endogenous Exposome” was first explored 
by our laboratory from the concept of the “Exposome” that emphasized the importance of 
understanding relationships between human disease and lifetime exposures to both 
environmental and internal chemicals (2). Recent advances have identified endogenous 
aldehydes as possible genotoxic agents that cause severe bone marrow failure (BMF) and 
leukemia in mice with mutations in both Fanconi anemia group D2 (fancd2) and aldehyde 
dehydrogenase 2 (Aldh2) (3). Notably, Aldh2 is mutated in ~1 billion people, most 
frequently observed in Southeast Asians due to inherited genetic mutations (4). Deficiency 
of Aldh2 has been demonstrated to dramatically accelerate BMF in Japanese Fanconi 
anemia patients (5). In addition, endogenous formaldehyde has been shown to have greater 
genotoxicity than acetaldehyde (6–8). These findings raise new challenges for understanding 
the cellular environments involved in disease causation. Linear extrapolation of risk down to 
zero remains a common approach used by regulators, despite the fact that such models use 
no biology and that when biology exists, linear extrapolation will over estimate risks (9). 
Thus, better understanding of endogenous and exogenous DPC data are important for 
advancing science-based risk assessments.
DNA-protein crosslinks (DPCs) strongly disrupt normal DNA-protein interactions and 
interfere with DNA replication, transcription, and repair, which ultimately threatens genomic 
integrity and cell viability (10). DPCs can originate from exposure to environmental agents 
such as ionizing radiation, UV light, formaldehyde and transition metal ions (11). 
Furthermore, anticancer drugs have been developed based on their ability to form DPCs, 
such as nitrogen mustards, platinum containing agents (i.e.: cisplatin), and 5-
aza-2’deoxycytidine. Notably, DPCs can also arise upon exposure to endogenous 
carcinogens, such as reactive aldehydes that are produced during various cellular processes 
(2,12). Due to their bulky nature, DPCs impact practically all aspects of genomic activity, 
and may therefore result in genomic instability or cell death. Thus, DPC formation and 
repair are crucial for genomic integrity in humans and consequently for understanding and 
preventing carcinogenesis (1,10,13–15). Surprisingly, however, DPC repair mechanisms 
have not been fully elucidated (15).
Until now, accurate and distinct measurements of both endogenous and exogenous DPCs 
have not been studied, which significantly limits our understanding of the biological effects 
and repair of DPCs. Accurate measurement of DPCs is complicated by two critical issues. 
First, covalent DPCs must be completely isolated from non-covalent DNA-protein 
complexes, since the latter are present in a clear excess over the former throughout the 
genome (16). Secondly, DPCs need to be measured with structural specificity, given that 
there are numerous lesions that complicate the background of DPCs resulting from both 
endogenous and exogenous electrophiles. However, such stringent measurements of DPCs 
have not been possible using previously available DPC detection techniques, such as 
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SDS/KCl precipitation, phenol-chloroform extraction, nitrocellulose filter binding, comet 
assay, alkaline elution, and CsCl density gradient centrifugation, all of which are 
nonselective (16,17). Recently, mass spectrometry-based methods have emerged as powerful 
tools for chemical analysis of digested DPCs (11). Elegant work using mass spectrometry 
has comprehensively characterized and ultra-sensitively quantified the DPCs induced by 
bifunctional electrophiles, such as nitrogen mustards (18,19), cisplatin and diepoxybutane 
(20).
Formaldehyde is classified as an animal and human carcinogen. Humans are exposed to 
formaldehyde originating from environmental sources due to its broad range of applications 
and formation from various chemical processes, as well as internal sources due to its role as 
an essential intermediate of various cellular processes (21). As a strong electrophile, 
formaldehyde is a well-known crosslinking agent that is cytotoxic, resulting in increased cell 
proliferation, mutagenesis and nasal carcinomas in rats exposed by inhalation (22). 
Formaldehyde has been widely used to elucidate the cellular pathways of DPC repair 
(8,10,23,24). Furthermore, endogenous formaldehyde is an important source of DNA 
damage (6,8). It thus poses unique challenges for understanding the risks associated with 
exposure. One major question that must be addressed is whether inhaled formaldehyde can 
increase the risk for leukemia. A critical dilemma has been to determine whether exogenous 
formaldehyde reaches bone marrow. To this end, we focused on the tissue distribution of 
endogenous and exogenous formaldehyde-induced DPC formation in rats and nonhuman 
primates (NHP) at exposure concentrations that had been studied in earlier DPC 
experiments, as well as in carcinogenicity studies in rats (25–27). For the first time, the 
incorporation of stable isotope labeled formaldehyde ([13CD2]-formaldehyde) in animal 
exposures permitted readily distinguishable measurements of endogenous and exogenous 
DPCs, based on their mass differences through the use of ultrasensitive and selective liquid 
chromatography-mass spectrometry. These measurements of endogenous and exogenous 
DPCs provide critical new data that advances science-based risk assessment, as well as 
providing improved methods for understanding pathways for DPC repair, such as the 
Fanconi anemia pathways that may lead to better disease treatment.
Materials and Methods
Chemicals and materials
2’-deoxyguanosine, reduced L-glutathione (GSH), sodium phosphate monobasic (BioXtra), 
sodium phosphate dibasic (BioXtra), magnesium chloride solution (1 M), calcium chloride 
solution (1 M), sucrose, ammonium acetate, acetic acid, formic acid, formaldehyde-DNPH 
standards, sodium cyanoborohydride (NaCNBH3), pronase, leucine aminopeptidase M, 
carboxypeptidase Y, prolidase, alkaline phosphatase, and phosphodiesterase were all 
purchased from Sigma (St Louis, MO). DNAzol and Turbo DNase were obtained from Life 
Technologies (Grand Island, NY). Methanol, acetonitrile, high-performance liquid 
chromatography (HPLC) grade water, and formaldehyde solution (37%, w/w) were all 
purchased from Thermo Fisher Scientific (Pittsburgh, PA). Formaldehyde solution was used 
to synthesize the dG-Me-Cys standard. [15N5, 13C10]-deoxyguanosine, [15N5]-
deoxyguanosine, [13CD2]-paraformaldehyde (≥98% purity), and [13CD2]-formaldehyde 
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solution (20% w/w in D2O) were ordered from Cambridge Isotope Laboratories, Inc. 
(Cambridge, MA). [15N5]-deoxyguanosine and [13CD2]-formaldehyde solution were used to 
synthesize the [15N5]-dG-[13CD2]-Me-Cys (Internal Standard). 2,4-Dinitrophenylhydrazine 
(DNPH) cartridges were ordered from Waters (Milford, Mass). Proteinase K (20 mg/ml) was 
obtained from 5 PRIME, Inc. (Gaithersburg, MD). Amicon Ultra Centrifugal Filters (0.5 ml, 
3K) were purchased from EMD Millipore (Darmstadt, Germany). Nanosep Centrifugal 
Devices (MWCO 3K) were purchased from Pall Life Sciences (Ann Arbor, MI).
Synthesis of dG-Me-Cys standard and internal standard
A synthesized standard, dG-Me-Cys, was prepared by digestion of dG-Me-Glutathione 
according to our previous study (28), using the experimental details described in the 
Supplementary Information. As demonstrated in a previous study, dG-Me-Cys showed a 
very close UV absorbance spectrum to that of dG (28). Thus, quantification of dG-Me-Cys 
was based on a dG standard calibration curve created using a HPLC-UV method with a 
detection wavelength at 254 nm. For the preparation of internal standard, [15N5]-
deoxyguanosine and [13CD2]-formaldehyde were used to synthesize [15N5]-dG-[13CD2]-
Me-Glutathione. Specifically, glutathione (100 mM) was incubated with [13CD2]-
formaldehyde (60 mM) in 1.0 ml sodium phosphate buffer (100 mM, pH 7.2) at 37 °C for 3 
h. [15N5]-dG was then added at a final concentration of 5 mM, and the crosslinking reaction 
was performed at 37 °C for 14 h. The same methods described in our previous study were 
applied for the purification and digestion of [15N5]-dG-[13CD2]-Me-Glutathione (28). The 
isolated [15N5]-dG-[13CD2]-Me-GSH was digested in 0.4 ml sodium phosphate buffer (40 
mM, pH 6.0) by carboxypeptidase Y (50 µg/ml), and leucine aminopeptidase M (250 µg/ml) 
in the presence of MgCl2 (10 mM) and CaCl2 (10 mM) at room temperature for 15 h. The 
internal standard, [15N5]-dG-[13CD2]-Me-Cys, was purified and quantified by the same 
method as described in Supplementary Information.
DNA-Protein Crosslink isolation and digestion
Animal exposure was described in the Supplementary Information. DPCs were isolated from 
animal tissue samples using DNAzol from Life Technologies (Carlsbad, CA) following the 
manufacturer’s instructions with some modifications. First, animal tissues (30–50 mg) were 
homogenized in 1 ml of sucrose buffer (20 mM sodium phosphate, 250 mM sucrose, pH 
7.2). The nuclei were isolated from homogenate solution by centrifugation at 1,500 × g and 
4 °C for 10 min. The nuclear pellets were washed with 1 ml of 20 mM sodium phosphate 
buffer (pH 7.2). The washed nuclear pellets were dissolved in 50 µl of water, followed by the 
addition of 800 µl of DNAzol and 20 µl of proteinase K (20 mg/ml). After protein digestion 
at room temperature for 15 hours, DPCs were precipitated by adding 600 µl of 100% 
ethanol. The precipitated DPCs were washed with 800 µl of 75% ethanol 4 times. The 
isolated DPCs were dissolved in 450 µl digestion buffer (20 mM ammonium acetate, pH 6.0) 
containing MgCl2 (5 mM), CaCl2 (5 mM), DNase I (40 U/ml), alkaline phosphatase (4 U/
ml), phosphodiesterase I (0.001 U/ml), and pronase (0.5 mg/ml). DNA digestion was 
performed at room temperature for 20 hours, resulting in the formation of nucleoside-
peptide crosslinks. The enzymes and undigested DNA were removed using a Nanosep 
Centrifugal Device (MWCO, 3K) at 10,000 × g and 4 °C for 40 min. The resultant filtrate 
was combined with 30 µl of an enzyme mixture containing carboxypeptidase Y (0.3 mg/ml), 
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aminopeptidase M (0.6 mg/ml), and prolidase (0.3 mg/ml) to further digest peptides to 
amino acids. Following a 20 hour incubation at room temperature, the reaction was 
terminated with the addition of 4 µl of 30% acetic acid. After adding 8 fmol of internal 
standard (4 µl, 2 nM), the final reaction mixtures were subjected to centrifugation at 10,000 
× g and 4 °C for 40 min in a Nanosep Centrifugal Device to remove enzymes prior to HPLC 
purification. In order to eliminate matrix interferences, digestion enzymes were washed 
before use as described in the Supplementary Information.
HPLC purification and fractionation
The target analyte, dG-Me-Cys, was purified from the reaction mixture on an Agilent 1200 
series UV HPLC system by using two C18 reverse phase columns connected in series 
(Waters Atlantis T3, 3 µm, 150 mm × 4.6 mm, Milford, MA). Following digestion, there 
were two products detected by HPLC-UV, both of which had similar retention times to that 
of DPCs. The use of two HPLC columns connected in series was found to greatly increase 
the resolution of HPLC separation between the dG-Me-Cys and the other digestion products. 
This increased the detection sensitivity of the DPC using nano-LC-ESI-MS/MS. The 
detection wavelength and column temperature were set at 254 nm and 15 °C, respectively. 
The mobile phases consisted of 0.05% acetic acid in water (A) and pure acetonitrile (B). The 
flow rate was 0.45 ml/min and elution gradient conditions were set as follows: 0 min, 1% B; 
3 min, 1% B; 42 min, 3% B; 86 min, 3.5% B; 86.5 min, 80% B; 95 min, 80% B; 95.5 min, 
1% B; 110 min, 1% B. dG-Me-Cys was eluted at a retention time of 81.5 min. The fractions 
containing target compounds were combined and concentrated to approximately 10–20 µl 
using a vacuum concentrator. The amount of digested dG in each sample was quantitated by 
the UV peak area (λ = 254 nm) at the corresponding retention time using a calibration curve 
ranging from 4 to 80 nmole dG on column.
Nano-LC-ESI-MS/MS analysis
Nano-LC-ESI-MS/MS analysis of dG-Me-Cys was performed on a TSQ Quantum Ultra 
triple-stage quadrupole mass spectrometer (Thermo Scientific, San Jose, CA) in positive-
mode electrospray ionization. Selected reaction monitoring (SRM) mode was used to detect 
and quantify dG-Me-Cys. Sample introduction and separation was accomplished on a nano-
Acquity Ultra Performance Liquid Chromatography system from Waters Corporation 
(Milford, MA). Following injection, the compounds were retained on two Symmetry C18 
trap columns (5 µm, 20 × 0.18 mm) connected in series, followed by sample separation on a 
HSS T3 analytical column (1.8 µm, 100 × 0.1 mm) from Waters Corporation (Milford, MA) 
at room temperature. Mobile phases consisted of water with 0.05% acetic acid (A) and 
acetonitrile (B). Analytes were first retained on two trap columns with a flow rate of 1.8 
µl/min of 1% mobile phase B for 3 min, followed by transfer to the analytical column. The 
flow rate was 0.4 µl/min and elution gradient conditions were set as follows: 0 min, 1% B; 3 
min, 1% B; 16 min, 50% B; 20 min, 1% B; 35 min, 1% B. Mass spectrometer conditions 
were set as the following: source voltage, 2200 V; temperature of ion transfer tube, 280 °C; 
skimmer offset, 0; scan speed, 75 ms; scan width, 0.7 m/z; Q1 and Q3 peak width, 0.7 m/z; 
collision energy, 31 eV; collision gas (argon), 1.5 arbitrary units. A sample volume of 5 µl 
was injected for analysis. Endogenous DPC (dG-Me-Cys) and exogenous DPC (dG-
[13CD2]-Me-Cys) were quantified by using the transition of m/z 401.1 to m/z 164.1, and m/z 
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404.1 to m/z 167.1, respectively. The transition of m/z 409.1 to m/z 172.1 was monitored for 
the internal standard ([15N5]-dG-[13CD2]-Me-Cys). Linear calibration curves were obtained 
using the ratio of integrated peak area of the analytical standard over that of the internal 
standard.
Method Validation for LC-ESI-MS/MS analysis
Standard curves were established by plotting the peak area ratios of solutions containing a 
fixed amount of internal standard ([15N5]-dG-[13CD2]-Me-Cys, 8.0 fmol) and increasing 
amounts of dG-Me-Cys from 0.15 to 6 fmol. The limit of quantification (LOQ) was 
determined as the amount of standard that produced a signal-to-noise ratio >10. To evaluate 
method accuracy and precision, analytical standard was spiked into the digested mixture of 
rat liver samples at three different levels (0.8, 2.0, and 5.0 fmol) followed by HPLC 
purification and concentration using a vacuum concentrator.
Artifact determination
The digestion process of DPCs isolated from animal tissues has the potential to generate 
some chemically reactive species, including nucleotides containing a hydroxymethyl group, 
hydroxymethyl-dG, dG, and peptides containing cysteine. These products could potentially 
crosslink to form artifactual dG-Me-Cys during sample preparation. Control studies were 
performed to determine the potential for artifactual formation of dG-Me-Cys. The extent of 
possible artifacts was evaluated in two ways. The first technique involved spiking isotope-
labeled [13C10, 15N5]-dG into the DPC solution to determine the potential for extrinsic 
formation of [13C10, 15N5]-dG-Me-Cys. Specifically, [13C10, 15N5]-deoxyguanosine (4 mM) 
was treated with 600 µl of 0.5 M NaCNBH3 for 48 hours at 37 oC. The treated 
[13C10, 15N5]-dG was spiked into an equal amount of dG produced from DNA digestion. 
This spiked sample was subjected to DNA and protein digestion, followed by HPLC 
purification and LC-ESI-MS/MS analysis as described above. The potential artifact, 
[13C10, 15N5]-dG-Me-Cys, was monitored using the corresponding transition of m/z 416.1 to 
m/z 174.1. The second technique to determine artifact formation employed NaCNBH3 to 
reduce active hydroxymethyl groups in DNA and protein during the isolation of DPCs. 
Specifically, all solutions used in the isolation of DPCs, including homogenate buffer, wash 
solution and DNazol, contained 20 mM NaCNBH3. For control samples, NaCNBH3 was 
excluded in all solutions used for DPC isolation.
Results
Isolation and detection of formaldehyde specific DPCs
To study the chemical identity of formaldehyde induced-DPCs, we investigated the in vitro 
crosslinking reaction between nucleosides and amino acids in the presence of formaldehyde 
(29). Our results demonstrated that dG and cysteine cross-linked in the presence of 
formaldehyde to form dG-Me-Cys. We hypothesized that this crosslink would serve as a 
specific DPC biomarker of formaldehyde exposure based on its relatively high stability and 
abundance. To test this hypothesis, we examined formaldehyde-induced DPCs, specifically 
dG-Me-Cys, in both rats and NHPs that were exposed to [13CD2]-formaldehyde using nose-
only and whole body inhalation chambers, respectively (Fig. 1a). The use of [13CD2]-
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formaldehyde permitted the differential measurement of endogenous and exogenous dG-Me-
Cys based on their mass difference (+3 m/z) by mass spectrometry. A challenging step in 
structurally specific analysis of DPCs is the digestion or hydrolysis of bulky DPCs into 
small molecules suitable for MS/MS analysis. Many DPCs are unstable and chemical 
hydrolysis is generally too harsh to preserve the DPC linkages for their chemical identities. 
To this end, we optimized a mixture of enzymes to digest large DPCs into small nucleoside-
amino acid crosslinks (dG-Me-Cys) under mild conditions (pH 6.0 and room temperature), 
thereby enabling preservation of the DPC chemical identity before MS analysis (Fig.1b and 
1c). After complete digestion, formaldehyde induced-DPCs were isolated by offline HPLC 
fraction collection along with the quantification of digested dG using UV absorbance at 256 
nm. Using authentic standards, the isolated endogenous and exogenous dG-Me-Cys were 
differentially quantified by mass spectrometry (Fig. 1d).
Nano UPLC-MS/MS method development for DPC analysis
Given the inherent advantage of improved sensitivity, we adopted a nanospray UPLC-ESI-
MS/MS methodology to measure dG-Me-Cys. The validated method exhibits ultra-
sensitivity, as well as excellent accuracy and precision. Both the standard (dG-Me-Cys) and 
the internal standard (IS) were detected at the same retention time (Fig. 2). The limit of 
quantification was 37.5 amol on the column (S/N = 10). Good linearity was observed in the 
concentration range from 0.15 to 6.0 fmol with an R2 value of 0.9993 (Supplementary Fig. 
S1). The accuracy of this method was greater than 93.4%, with precision being less than 
11.2% RSD using three spiking concentrations: 0.8, 2.0 and 5 fmol (Supplementary Table 
S1).
The validated method was then utilized to identify endogenous and exogenous 
formaldehyde-specific DPCs in rat nasal tissue (respiratory epithelium) as shown in Fig. 3. 
Only the endogenous peak (dG-Me-Cys) corresponding to the specific transition of m/z 
401.1 to m/z 164.1 was detected in control rat nasal tissue at the same retention time as the 
internal standard at 14.20 min (Fig. 3a). Both endogenous and exogenous crosslinks were 
detected in [13CD2]-formaldehyde exposed rat nasal tissue at the same chromatographic 
retention time (Fig. 3b). The exogenous DPC fragment ions retained the stable isotope label, 
demonstrating the predicted isotope mass shift (+3 m/z) and were clearly distinguished from 
fragment ions of endogenous origin.
Artifact determination for the validated method
The potential for artifactual dG-Me-Cys formation during sample processing was 
investigated in two ways. First, stable isotope-labeled [13C10, 15N5]-dG was spiked into the 
reaction mixture to investigate whether free dG from the DNA digestion could form the 
crosslink. The potential formation of artifact, [13C10, 15N5]-dG-Me-Cys, was monitored 
using the corresponding transition of m/z 416.1 to m/z 174.1. The results showed that 
endogenous dG-Me-Cys and internal standard were observed as shown in the top and middle 
panels of Fig. 4a, respectively. On the contrary, no peak corresponding to the artifactual 
formation of [13C10, 15N5]-dG-Me-Cys was found in the same sample (Fig. 4a, bottom 
panel). This evidence demonstrated that the digestion of dG does not lead to artifactual 
formation of dG-Me-Cys during sample preparation. The second technique employed 
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sodium cyanoborohydride (NaCNBH3) to reduce active hydroxymethyl groups that could 
possibly form artifactual dG-Me-Cys (Fig. 4b). The results demonstrated that the reduction 
of hydroxymethyl groups did not change the amount of dG-Me-Cys in rat liver samples. 
These data imply that the digested dG and other products do not generate artifacts that 
interfere with the detection of DPCs.
Distribution of formaldehyde-induced DPCs in rats and monkeys
Using this sensitive method, endogenous and exogenous formaldehyde-induced DPCs were 
distinctly quantified in selected tissues (nasal epithelium, peripheral blood mononuclear 
cells (PBMC), bone marrow, and liver) of animals exposed to either filtered air only or 
[13CD2]-formaldehyde. Consistent results from rat and NHP studies clearly demonstrate that 
exogenous DPCs were only found in the nasal epithelium of animals exposed to varying 
amounts of [13CD2]-formaldehyde. Specifically, exogenous DPCs were detected at 1.36 
± 0.20 crosslinks/108 dG in NHP nasal tissues exposed to [13CD2]-formaldehyde with a 
targeted aerosol concentration of 6.0 ppm for 2 consecutive days (6h per day) (Table 1). A 
much higher number of exogenous DPCs were measured at 18.18 ± 7.23 crosslinks/108 dG 
in the rat nasal tissues from animals exposed to [13CD2]-formaldehyde at a targeted 
concentration of 15 ppm for 4 consecutive days (6h per day) (Table 2). In contrast to the 
exogenous DPCs, endogenous DPCs were present in all examined tissues in both air control 
and exposed animals. Surprisingly, endogenous DPCs were present at higher amounts, 
compared to exogenous DPCs in exposed NHP nasal tissue (Table 1). More strikingly, the 
number of endogenous DPCs (15.46 ± 1.98 crosslinks/108 dG) in air control NHP livers, 
was close to the highest amounts of exogenous DPCs (18.18 ± 7.23 crosslinks/108 dG) 
observed in the rat nasal tissues exposed to 15 ppm [13CD2]-formaldehyde for 4 consecutive 
days, a highly carcinogenic exposure concentration in the rat cancer bioassays (30–32).
Formation and elimination of formaldehyde-induced DPCs in rat nasal tissues
To monitor the induction and elimination of DPCs, we applied our method to investigate the 
accumulation and persistence of formaldehyde induced-DPCs in rat nasal tissues. As shown 
in Tables 2 and 3, both high and low exposure concentrations of inhaled formaldehyde gave 
rise to accumulation of exogenous DPCs in rat nasal tissues. At a high exposure 
concentration of 15 ppm [13CD2]-formaldehyde, similar amounts of exogenous DPCs were 
detected in 1-day and 2-day exposed rat nasal tissues (5.52 ± 0.80 and 4.69 ± 1.76 
crosslinks/108 dG), while 4-day exposed rat nasal tissues showed a dramatic increase in the 
formation of exogenous DPCs (18.18 ± 7.23 crosslinks/108 dG) (Table 2). In contrast to the 
large changes in exogenous DPC formation, less difference in the amounts of endogenous 
DPCs were present in the same samples, suggesting that the endogenous DPCs were at 
steady-state concentrations. Most importantly, exogenous DPCs showed little change in the 
animals exposed for 28 days with either a 24 or 168 hour (7 day) post exposure recovery 
period (Table 3), indicating high stability and long-term persistence of DPCs with the dG-
Me-Cys linkage. The discovery of accumulation and persistence of formaldehyde-DPCs 
highlights the need for a better understanding of DPC stability and repair.
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Discussion
Formaldehyde was first shown to be an animal carcinogen in 1980, causing squamous cell 
carcinomas in the nasal passages of exposed rats at concentrations at or above 6 ppm 
(30,31). Recent epidemiological studies have suggested that exposure to formaldehyde 
vapors may lead to the development of hematopoietic cancers such as leukemia, however 
these findings remain under debate (28,33–37). While leukemia has been a major finding in 
epidemiology studies of inhaled formaldehyde, no mechanism for leukemia has been 
established. The International Agency for Research on Cancer (IARC) working group also 
was not in full agreement on the evaluation of formaldehyde causing leukemia in humans 
(22,38). A recent paper by Coggon et al., did not find any leukemias in one of the largest 
cohorts of formaldehyde workers, even though some of those workers were exposed to 
inhaled formaldehyde at concentrations much higher than 2 ppm (37). In addition, the 
induction of leukemia by inhaled formaldehyde exposures has not been supported in rat 
carcinogenicity studies (39). Previous studies in rats and NHP also have not found any 
evidence that inhaled [13CD2]-formaldehyde reached the bone marrow as exogenous DNA 
adducts (28,34).
Endogenous formaldehyde is produced as an essential metabolic intermediate by enzymatic 
and nonenzymatic pathways, and as a detoxification product of xenobiotics during cellular 
metabolism (40). It is well understood that endogenous formaldehyde originates from 
numerous sources including one-carbon pool metabolism, amino acid metabolism, methanol 
metabolism, lipid peroxidation, cytochrome P450–catalyzed demethylation, and histone 
demethylation reactions (34,41,42). Endogenous formaldehyde has been assumed to be 
present in all aqueous body fluids because of its water solubility. Its half-life in humans is 
estimated to be 1–1.5 min (43). In particular, the concentration of endogenous formaldehyde 
was detected at ~0.1 mM in the blood of rats, monkeys, and humans (22,44–46). In addition, 
endogenous formaldehyde was found to be 2–4 times higher in the liver and nasal mucosa 
than in the blood of a rat (47). Endogenous formaldehyde is also formed in cellular nuclei, 
secondary to demethylation of histone III (42). These formaldehyde molecules are released 
in close proximity to DNA, providing an important source for bone marrow DPC and 
formaldehyde monoadducts (42). Thus, with endogenous formaldehyde-induced DNA 
adducts and DPC present in all tissues examined, but a complete lack of exogenous DNA 
adducts and DPC in tissues distant to the portal of entry (6,28), the key issue that must be 
addressed by risk assessors and epidemiologists is whether or how exogenous formaldehyde 
exposure could increase cancer risks at distal sites.
Due to their significant biological consequences, formaldehyde-induced DPCs have long 
been recognized as a highly mutagenic form of formaldehyde DNA damage. The amounts of 
formaldehyde-induced DPCs are considered to represent a good molecular biomarker of 
formaldehyde exposure (6,48). However, the lack of robust DPC measurements have limited 
our understanding of the genotoxic activity of formaldehyde. Previous studies using 
chloroform/iso-amyl alcohol/phenol extraction based DPC isolation following inhaled 
formaldehyde exposures in rats and NHPs found increased amounts of DPC formation in the 
nasal tissue but not in tissues distant from the portal of entry (25,27). In contrast, increased 
numbers of DPCs were detected in circulating lymphocytes of workers occupationally 
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exposed to formaldehyde, and in remote tissues, such as bone marrow, liver, kidney, and 
testes of mice exposed to inhaled formaldehyde using SDS/KCl precipitation based DPC 
isolation (49,50). This scientific dispute may be due to the major disadvantage of previous 
DPC assays that were unable to provide chemical identity for specific and accurate 
measurements of DPCs. Furthermore, it is has been impossible to distinguish endogenous 
from exogenous formaldehyde-induced DPCs prior to the use of stable isotopes.
In particular, the National Research Council (NCR) committee considered our earlier work 
using sensitive and distinct measurements between exogenous and endogenous 
formaldehyde-induced DNA adducts as being highly informative and should be incorporated 
in the EPA’s draft Integrated Risk Information System (IRIS) assessment (34,48). Moreover, 
the NRC committee suggested that DPCs play a more important role in formaldehyde 
genotoxicity and carcinogenicity compared to DNA adducts (48). This study provides 
accurate measurements that discriminate between endogenous and exogenous DPCs through 
the use of stable isotope formaldehyde exposures and ultrasensitive mass spectrometry. Our 
data demonstrate that exogenous DPCs were only found in nasal samples of exposed 
animals, but not in sites remote to the portal of entry. Consistently, our previous studies 
reported that inhaled formaldehyde-induced DNA adducts and protein adducts were only 
detected in rat and NHP nasal tissues, but not in other tissues such as lung, liver, bone 
marrow and PBMC (28,34,51). These findings suggest that there is no additional dose to the 
bone marrow beyond that from endogenous formaldehyde. The lack of exogenous DPCs in 
remote tissues does not support a plausible relationship between inhaled formaldehyde and 
increased risks of leukemia. On the other hand, with high amounts of endogenous 
formaldehyde always present in all cells, one would expect the induction of disease states by 
this highly reactive aldehyde. Our previous work identified specific DNA adducts (N2-Me-
dG) and DNA-DNA crosslinks (dG-Me-dG) induced by endogenous formaldehyde (34). 
This study provides the first evidence to the existence of endogenous formaldehyde-induced 
DPCs in all examined tissues. Furthermore, the recent paper by our lab and KJ Patel’s group 
clearly demonstrated that endogenous formaldehyde is a hematopoietic genotoxin and a 
metabolic carcinogen (6). Additionally, as recently reported, as many as 1/3 of the acute 
myeloid leukemia patients have deficiencies in aldehyde dehydrogenases that play important 
roles in preventing DNA damage by detoxifying endogenous aldehydes (52). Thus, recent 
medical research has provided strong data that better explain the formaldehyde 
epidemiology findings.
Formaldehyde-induced DPCs had been considered to be unstable in cell and animal studies. 
A rapid decline of the formaldehyde-induced DPCs was reported in cell culture, and there 
was no accumulation of DPCs observed in rat nasal tissues after repeated exposure 
(16,53,54). However, the present study demonstrated that exogenous DPCs accumulated 
with exposure time and showed little change after one week post exposure. Previous 
inconsistent results may be due to the use of non-structurally specific measurements which 
are highly susceptible to the interference of non-covalent DNA protein complexes. Although 
DPC repair mechanisms have not been well understood, proteolysis of the protein 
components of the DPC to small peptides has been reported as a protease-based DNA repair 
pathway specific for DPCs (10,11,15,55). The present study measures single amino acid-
nucleoside crosslinks, specifically dG-Me-Cys. The small change in the amount of dG-Me-
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Cys measured one week post exposure does not rule out the possibility that the protein 
components of DPCs as a whole, do not undergo proteolytic degradation to small peptides. 
In a recent study, synthesized DPCs, including dG-Me-Cysteine, dG-Me-Glutathione, and 
dG-Me-Peptide crosslinks, were found to undergo rapid hydrolysis in vitro (28). The long 
term persistence of DPCs observed in vivo is likely due to the steric hindrance and localized 
hydrophobic conditions of DNA and the associated protein that greatly increase DPC 
stability.
The success of distinctly measuring endogenous and exogenous formaldehyde-DPCs has 
demonstrated the importance of structurally specific DPC data. The lack of exogenous DPCs 
in remote tissues away from the portal of entry suggest that the effects of inhaled 
formaldehyde may have been overemphasized, while endogenous formaldehyde has been 
underappreciated as a source of exposure leading to the induction of leukemia. The finding 
of exogenous DPC accumulation during inhalation exposure and its minimal repair 
following one week post exposure, provides the first evidence of long-term persistence of 
DPCs. The discovery of endogenous DPCs in all tissues examined raises an important 
perspective on the potential health risks posed by endogenous formaldehyde. Considering 
the high background of endogenous DPCs, it would be impossible to measure the induction, 
distribution, and elimination of exogenous DPCs without exogenous DPC measurements, 
particularly at low levels of exposure.
Future applications of this method include, but are not limited to 1) investigation of DPC 
repair mechanism(s) in vivo using formaldehyde-induced DPCs; 2) understanding whether 
and how the Fanconi anemia genes are involved in aldehyde induced-DPC repair; 3) 
application of such data for science-based risk assessment of aldehydes in a manner that 
contributes to the EPA’s IRIS program assessment of formaldehyde and aldehydes in 
general; 4) utilizing structurally specific methodologies to determine the makeup of DPCs 
induced by various endogenous and exogenous agents such as malondialdehyde, 4-
hydroxynonenal, acrolein and aldehydic lesions present on abasic sites. Likewise, DPCs 
associated with exogenous anticancer drugs can be better understood, contributing to further 
advancements of chemotherapy. In summary, this study provides a new approach to 
accurately determine the roles of endogenous and environmental DPCs to form mutagenic 
DNA damage as factors that contribute to disease and provide more accurate data that can 
improve cancer risk assessments.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Experimental workflow for distinct measurement of endogenous and exogenous DPCs. (a) 
Animals were exposed to [13CD2]-formaldehyde by inhalation. The use of [13CD2]-
formaldehyde allowed the differentiation of endogenous and exogenous dG-Me-Cys 
crosslinks having the same chemical identity, but different masses. (b) DPCs were isolated 
from animal tissues using a DNAzol method. (c) DPCs were digested to nucleoside-amino 
acid crosslinks by DNA and protein enzymes, followed by offline HPLC purification of 
formaldehyde-DPCs, along with quantification of digested dG; (d) Endogenous and 
exogenous formaldehyde-DPCs were differentially quantified as the corresponding dG-Me-
Cys using Nano LC-MS/MS. The normalization of DPC concentration was achieved by 
calculating the ratio of the amount of dG-Me-Cys to digested dG.
Lai et al. Page 15
Cancer Res. Author manuscript; available in PMC 2017 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. 
Typical Nano-LC-ESI-MS/MS-SRM chromatogram and calibration curve of dG-Me-Cys. 
Nano-LC-ESI-MS/MS-SRM chromatograms of dG-Me-Cys (0.0375 fmol) and Internal 
Standard [15N5]-dG-[13CD2]-Me-Cys (0.5 fmol). NL = normalized spectrum to largest peak 
in particular chromatogram.
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Figure 3. 
Distinct detection of endogenous and exogenous dG-Me-Cys in control and exposed rat 
noses by Nano LC-MS/MS. NL, normalized spectrum to largest peak in this particular 
chromatogram.
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Figure 4. 
Evaluation of artifactual formation of dG-Me-Cys. (a) Artifact determination in a rat liver 
sample spiked with isotope labeled [13C10, 15N5]-dG. (b) Relative amount of endogenous 
dG-Me-Cys in rat liver samples treated without (Control Sample) and with NaCNBH3 
(Reduced Sample). Error bars represent the standard deviation of three individual 
experiments.
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Table 1
Formaldehyde-induced dG-Me-Cys in nose, peripheral blood mononuclear cells (PBMC), bone marrow, and 
liver of primates exposed to air control vs. 6 ppm of [13CD2]-formaldehyde (6 h per day).
Tissue
Targeted [13CD2]-
Formaldehyde
Concentration (ppm)
Exposure
period
(days)
dG-Me-Cys (crosslink/108 dG)
Endogenous Exogenous
Nose
Air Control 2 3.59 ± 1.01 (n=5) ND*
6 ppm 2 3.76 ± 1.50 (n=5) 1.36 ± 0.20
PBMC
Air Control 2 1.34 ± 0.25 (n=5) ND
6 ppm 2 1.57 ± 0.58 (n=4) ND
Bone
Marrow
Air Control 2 2.30 ± 0.30 (n=4) ND
6 ppm 2 1.40 ± 0.46 (n=5) ND
Liver
Air Control 2 15.46 ± 1.98 (n=6) ND
6 ppm 2 11.80 ± 2.21 (n=6) ND
*ND, Not Detected.
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Table 2
Formaldehyde-induced dG-Me-Cys in nasal tissue, peripheral blood mononuclear cells (PBMC), and bone 
marrow of rats exposed to Air Control verses 15 ppm of [13CD2]-formaldehyde (6 h per day).
Tissue
Targeted [13CD2]-
Formaldehyde
Concentration (ppm)
Exposure
period
(days)
dG-Me-Cys (crosslink/108 dG)
Endogenous Exogenous
Nasal
0 - Air Control 4 6.50 ± 0.30 (n=5) ND
15.0 1 4.42 ± 1.10 (n=6) 5.52 ± 0.80
15.0 2 4.28 ± 2.34 (n=6) 4.69 ± 1.76
15.0 4 3.67 ± 0.80 (n=6) 18.18 ± 7.23
PBMC
0 - Air Control 4 4.98 ± 0.61 (n=5) ND
15.0 1 3.26 ± 0.73 (n=4) ND
15.0 2 3.00 ± 0.98 (n=5) ND
15.0 4 7.19 ± 1.73 (n=5) ND
Bone
Marrow
0 - Air Control 4 1.64 ± 0.49 (n=4) ND
15.0 1 1.80 ± 0.47 (n=4) ND
15.0 2 1.84 ± 0.61 (n=4) ND
15.0 4 1.58 ± 0.38 (n=4) ND
ND, Not Detected.
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Table 3
Formaldehyde-induced dG-Me-Cys in nose of rats exposed to 2 ppm of [13CD2]-formaldehyde (6 h per day) 
for up to 28 days..
Exposure period (day)
dG-Me-Cys (crosslink/108 dG)
Endogenous Exogenous
7 days 4.78 ± 0.64 (n=4) 0.96 ± 0.17
28 days 4.51 ± 1.48 (n=3) 2.46 ± 0.44
28 days + 24h post
exposure
3.78 ± 0.69 (n=4) 2.12 ± 1.00
28 days + 168h post
exposure
3.51 ± 0.16 (n=3) 2.14 ± 1.02
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